Full Text View
Tabular View
Study Results
Related Studies
Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i
This study has been completed.
Study NCT00750308   Information provided by Vanderbilt University

First Received on September 5, 2008.   Last Updated on October 13, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metabolic Syndrome
Additional conditions recognized in this trial
Metabolic Syndrome X
More general conditions related to this trial
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Metabolic Diseases
Interventions listed in this trial
Ramipril and placebo
Tadalafil and placebo
placebo and placebo
tadalafil and ramipril
Additional drug interventions recognized in this trial
Ramipril
Tadalafil
More general drug interventions related to this trial
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Protease Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Vanderbilt University
National Institutes of Health (NIH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services